查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468258

2024-2032 年癌症恶病质市场报告（依治疗方法、作用方式、配销通路和地区）

Cancer Cachexia Market Report by Therapeutics, Mode of Action, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球癌症恶病质市场规模达21亿美元。

癌症恶病质是指多因素的宿主吞噬消耗综合征，其特征是系统性发炎、无意识的瘦体重损失、蛋白质负平衡、食慾不振和肌肉萎缩。它是由多种慢性疾病的发生引起的，包括结核病（TB）、多发性硬化症、慢性阻塞性肺病（COPD）和人类免疫缺陷病毒（HIV）。癌症恶病质可以使用多种疗法来治疗，例如黄体素、皮质类固醇和联合疗法。其中，黄体素是一种合成或天然类固醇激素，可改善食慾并促进体重增加，而皮质类固醇有助于减轻发炎和抑制过度活跃的免疫系统。

癌症恶病质市场趋势：

癌症和恶病质的盛行率不断增加，特别是在不断增加的老年人口中，促进了对先进治疗方法和药物的需求，这反过来又主要推动了市场的成长。消费者对治疗癌症恶病质的新型治疗药物的可用性的认识不断提高，进一步支持了这一点。此外，患者转向透过药物、非药物治疗和临床试验改善去脂体重（LBM）的联合治疗的倾向正在成为另一个生长诱导因素。与此一致的是，用于改善消化的多种食慾兴奋剂（例如醋酸甲地孕酮、地塞米松和甲基强的松龙）的广泛使用也促进了市场的成长。此外，强调开发治疗癌症恶病质的有效药物的重大技术进步进一步推动了市场成长。除此之外，各国政府机构和非政府组织（NGO）采取了许多有利倡议，提高人们对癌症恶病质的原因、症状和使用先进治疗的好处的认识，这为癌症恶病质的发展创造了积极的前景。

本报告回答的关键问题

  • 2023 年全球癌症恶病质市场规模有多大？
  • 2024-2032年全球癌症恶病质市场的预期成长率是多少？
  • 推动全球癌症恶病质市场的关键因素是什么？
  • COVID-19 对全球癌症恶病质市场有何影响？
  • 基于治疗方法的全球癌症恶病质市场的细分情况如何？
  • 根据作用方式，全球癌症恶病质市场的细分如何？
  • 全球癌症恶病质市场的关键地区有哪些？
  • 全球癌症恶病质市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球癌症恶病质市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依治疗学分类

  • 黄体素
    • 市场走向
    • 市场预测
  • 皮质类固醇
    • 市场走向
    • 市场预测
  • 联合疗法
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按行动模式

  • 食慾刺激器
    • 市场走向
    • 市场预测
  • 减肥稳定剂
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院商店
    • 市场走向
    • 市场预测
  • 零售药房
    • 市场走向
    • 市场预测
  • 网路药房
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AAVogen Inc.
    • Actimed Therapeutics Ltd.
    • Aphios Corporation
    • Artelo Biosciences Inc.
    • AVEO Pharmaceuticals Inc.
    • Fresenius Kabi AG (Fresenius SE & Co. KGaA)
    • Helsinn Healthcare SA
    • Merck & Co. Inc.
    • NGM Biopharmaceuticals Inc.
    • Pfizer Inc.
    • Tetra Bio-Pharma
Product Code: SR112024A5338

The global cancer cachexia market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.

Cancer cachexia refers to a multifactorial, host-phagocytic, wasting syndrome that is characterized by systematic inflammation, involuntary loss of lean body mass, negative protein balance, loss of appetite and muscle atrophy. It is caused due to the occurrence of various chronic diseases, including tuberculosis (TB), multiple sclerosis, chronic obstructive pulmonary disease (COPD) and human immunodeficiency virus (HIV). Cancer cachexia can be treated with the utilization of various therapeutics, such as progestogen, corticosteroid, and combination therapy. Amongst these, a progestogen is a synthetic or natural steroid hormone that improves appetite and promotes weight gain, whereas corticosteroid assists in mitigating inflammation and suppressing overactive immune systems.

Cancer Cachexia Market Trends:

The increasing prevalence of cancer and cachexia, especially amongst the rising geriatric populations, is facilitating the demand for advanced therapeutic treatment and drugs, which in turn, is primarily driving the market growth. This is further supported by the increasing awareness amongst consumers regarding the availability of novel therapeutic drugs to treat cancer cachexia. Additionally, the shifting inclination of patients toward combinational therapies for improving lean body mass (LBM) through pharmacological, non-pharmacological therapies and clinical trials is acting as another growth-inducing factor. In line with this, the extensive utilization of several appetite stimulants, such as megestrol acetate, dexamethasone, and methylprednisolone, for improving digestion is also contributing to the market growth. Moreover, significant technological advancements that are emphasizing on the development of effective medicines for cancer cachexia treatment are further propelling the market growth. Apart from this, the numerous favorable initiatives being undertaken by the government bodies of various countries and non-governmental organizations (NGOs) for sensitizing people regarding the causes of cancer cachexia, their symptoms and benefits of using advanced treatments are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer cachexia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutics, mode of action and distribution channel.

Breakup by Therapeutics:

Progestogens

Corticosteroids

Combination Therapy

Others

Breakup by Mode of Action:

Appetite Stimulators

Weight Loss Stabilizers

Breakup by Distribution Channel:

Hospital Stores

Retail Pharmacy

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Artelo Biosciences Inc., AVEO Pharmaceuticals Inc., Fresenius Kabi AG (Fresenius SE & Co. KGaA), Helsinn Healthcare SA, Merck & Co. Inc., NGM Biopharmaceuticals Inc., Pfizer Inc. and Tetra Bio-Pharma.

Key Questions Answered in This Report

  • 1. What was the size of the global cancer cachexia market in 2023?
  • 2. What is the expected growth rate of the global cancer cachexia market during 2024-2032?
  • 3. What are the key factors driving the global cancer cachexia market?
  • 4. What has been the impact of COVID-19 on the global cancer cachexia market?
  • 5. What is the breakup of the global cancer cachexia market based on the therapeutics?
  • 6. What is the breakup of the global cancer cachexia market based on the mode of action?
  • 7. What are the key regions in the global cancer cachexia market?
  • 8. Who are the key players/companies in the global cancer cachexia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cancer Cachexia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutics

  • 6.1 Progestogens
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Corticosteroids
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Mode of Action

  • 7.1 Appetite Stimulators
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Weight Loss Stabilizers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Stores
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AAVogen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Actimed Therapeutics Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Aphios Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Artelo Biosciences Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 AVEO Pharmaceuticals Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Helsinn Healthcare SA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 NGM Biopharmaceuticals Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tetra Bio-Pharma
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Cancer Cachexia Market: Major Drivers and Challenges
  • Figure 2: Global: Cancer Cachexia Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cancer Cachexia Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cancer Cachexia Market: Breakup by Therapeutics (in %), 2023
  • Figure 5: Global: Cancer Cachexia Market: Breakup by Mode of Action (in %), 2023
  • Figure 6: Global: Cancer Cachexia Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Cancer Cachexia Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cancer Cachexia (Progestogens) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Cancer Cachexia (Progestogens) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Cancer Cachexia (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Cancer Cachexia (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Cancer Cachexia (Combination Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cancer Cachexia (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cancer Cachexia (Other Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cancer Cachexia (Other Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cancer Cachexia (Appetite Stimulators) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cancer Cachexia (Appetite Stimulators) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cancer Cachexia (Weight Loss Stabilizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cancer Cachexia (Weight Loss Stabilizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cancer Cachexia (Hospital Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cancer Cachexia (Hospital Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cancer Cachexia (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cancer Cachexia (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cancer Cachexia (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cancer Cachexia (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Cancer Cachexia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Cancer Cachexia Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Cancer Cachexia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Cancer Cachexia Industry: SWOT Analysis
  • Figure 76: Global: Cancer Cachexia Industry: Value Chain Analysis
  • Figure 77: Global: Cancer Cachexia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cancer Cachexia Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cancer Cachexia Market Forecast: Breakup by Therapeutics (in Million US$), 2024-2032
  • Table 3: Global: Cancer Cachexia Market Forecast: Breakup by Mode of Action (in Million US$), 2024-2032
  • Table 4: Global: Cancer Cachexia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Cancer Cachexia Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Cancer Cachexia Market: Competitive Structure
  • Table 7: Global: Cancer Cachexia Market: Key Players